Download presentation
Presentation is loading. Please wait.
Published byPercival Townsend Modified over 5 years ago
1
ACCORD Update Event Fiona McArdle Deputy R&D Director Wellcome Auditorium Queen’s Medical Research Institute 26th February 2019
2
Overview of ACCORD Joint Research Framework Agreement Key Functions
NHS Research Scotland (NRS) Funding for Lothian Clinical Research Infrastructure in Lothian NRS Objectives & Performance Targets ACCORD Metrics
3
ACCORD The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint office comprising clinical research management staff from NHS Lothian & the University of Edinburgh Joint Research Framework Agreement Established in 2006 to streamline R&D support for clinical researchers in Edinburgh & to facilitate high quality collaborative research ACCORD provides central access to professional advice, expert regulatory support & world class clinical research infrastructure
4
Key Functions R&D management approval Contracts and agreements Caldicott approval Research passport Intellectual Property QA and monitoring PPI Advice Research governance & GCP Sponsorship Grant applications & costings Advice & facilitation Regulatory submissions Pharmacovigilance
5
NHS Research Scotland (NRS) Funding
15% absolute funding reduction between 2014/15 & 2017/18
7
Clinical Research Infrastructure
Edinburgh Clinical Research Facilities: WTCRF Education Programme: Edinburgh Imaging: Edinburgh Clinical Trials Unit: Clinical Trials Pharmacists: Investigational Supplies Group, now part of the Health Technology Accelerator Facility (HTAF): Biorepository: Lothian Research Safe Haven: Patient & Public Involvement Advisor:
8
NRS Objectives & Performance Targets
Increase or sustain activity: number of studies and subjects recruited Increase grant and commercial income Achieve target R&D permission times Work collaboratively with industry & other Scottish Health Boards
9
Number of studies undertaken by year
10
Recruitment by year
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.